The intervention effect of ESM Cluster Nursing Model in Type 2 Diabetes Inpatients with High Risk Factors of Diabetic Foot
ZHOU Lihuan1, XU Jingcan2, HAN Huiwu2, DAI Weiwei2, PENG Min3, ZHAO Nan4, LI Xinyi2, LUO Wenjing5, YU Ling2, ZHOU Qiuhong6
1. Department of Cardiothoracic Surgery, Hunan Children's Hospital, Changsha 410007; 2. Deparment of Narsing, Xiangya Hospital, Central South University, Changsha 410008; 3. Institute of Geriatrics, Guangdong General Hospital, Guangzhou 510000; 4. Zhengzhou Shuqing Medical College, Zhengzhou 450064; 5. Tumor Center, West China Hospital, Sichuan University, Chengdu 610041; 6. Diabetic foot care center, Xiangya Hospital, Central South University, Changsha 410008
Abstract：Objective To explore the effect of ESM cluster nursing mode on foot nursing knowledge, behavior, foot skin condition, anxiety and depression in hospitalized type 2 diabetes high-risk foot patients. Methods From September to December 2022, a total of 88 cases of high-risk foot patients with type 2 diabetes in the Department of Endocrinology of a Grade A tertiary hospital in Changsha, Hunan Province were selected as the study objects by convenient sampling method, and were divided into control group and intervention group with 44 cases in each group. The control group received routine care, and the experimental group received ESM cluster care mode on this basis, and the intervention time was 1 month. The patients' foot care knowledge, foot care behavior, anxiety and depression, and foot skin condition were evaluated and investigated before and after the intervention. Results The improvement of foot care knowledge, foot care behavior and anxiety and depression in the intervention group was better than that in the control group, and the foot skin condition was significantly improved, with statistical significance. Conclusion The ESM cluster nursing mode can effectively improve foot nursing knowledge, promote foot nursing behavior, reduce foot skin abnormality rate, and improve anxiety and depression of patients with type 2 diabetes.
[1] PENGZI, ZHANG, JING, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis[J]. Ann Med, 2017, 49(2): 106-116. [2] ALAVI A, SIBBALD R G, Mayer D, et al.Diabetic foot ulcers: Part I. Pathophysiology and prevention[J]. J Am Acad Dermatol, 2014, 70(1): 19-20. [3] International Diabetes Federation. IDF Diabetes Atlas, 8th. Brussels: 2017[EB/OL]. [2019-01-02]. http://www. diabetesatlas. org. [4] LI L, CHEN J, WANG J, et al.Prevalence and risk factors of diabetic peripheral neuropathy In type 2 diabetes mellitus patients with overweight/obesein Guangdongprovince, China[J]. Prim Care Diabetes, 2015, 9(3): 191-195. [5] 关小宏, 李宝军, 肖黎, 等. 糖尿病足流行病学及糖尿病足截肢 (趾) 的临床情况分析[J]. 中华损伤与修复杂志电子版, 2012, 07(4): 56-58. [6] 李会娟. 糖尿病高危足患者筛查方法的研究进展[J]. 护士进修杂志, 2016, 31(9): 786-789. [7] 马睛雅, 田润溪, 李佳玥, 等. 糖尿病高危足病人足部管理认知、行为及需求的质性研究[J]护理研究, 2019, 33(10): 1782-1785. [8] 李饶, 袁丽, 郭晓蕙, 等. 中国2型糖尿病患者足部护理知识和足部自我护理行为现状及影响因素的研究[J]. 中华护理杂志, 2014, 49(8): 909-913. [9] 王升英, 初慧中, 于雁, 等. 集束化护理在老年患者骨科术后下肢深静脉血栓预防中的效果观察[J]. 中国护理管理, 2016, 16(2): 263-265. [10] 李燕英, 叶志珍, 刘莹 . 集束化护理在门诊 PICC 导管维护患者中的应用[J]. 齐鲁护理杂志, 2016, 22(12): 34-35. [11] 宛丽, 于巧秀, 王红. 集束化护理应用于预防手术部位感染的探讨[J]. 护士进修杂志, 2014, 29(14): 1334-1336. [12] 康馨匀, 张继伟, 熊露宁, 等. 集束化护理预防呼吸睡眠暂停并脑卒中的作用分析[J]. 中国实用神经疾病杂志, 2015, (3): 122-123. [13] 乔美娜. 社区糖尿病患者高危足筛查及足部护理知识和行为状况调查[D]. 保定: 河北大学, 2017. [14] MACFARLANE RM, JEFF COATE WJ.Factors contributing to the presentation of diabetic foot ulcers[J]. Diabet Med, 1997, 14(10): 867-870. [15] ADLER AI, BOYKO EJ, AHRONI JH, et al.Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers[J]. Diabetes Care, 1999, 22(7): 1029-1035. [16] 李静. 三种健康教育方法对2型糖尿病足高危患者足部护理行为影响的比较研究[D]. 天津: 天津医科大学, 2015. [17] 姜乾金. 医学心理学[M]. 北京: 人民卫生出版社, 2004: 6. [18] 何叶, 董颖越, 董燕, 等. 看图对话工具在糖尿病患者健康教育中的应用进展[J]. 中国护理管理, 2013, (11): 75-77. [19] HERNANDER CA, ARNOTT CA, BRADISH G, et al. Reducing Foot Complications for People with Diabetes. Toronto, Canada: Registered Nurses Association of Ontari[DB/OL]. Lttps: //nao. ca/bpg/guidelines/reducing-foot-complications-people-diabetes.2007-03/2023-12-10. [20] KATERYNA A, ERICA D, KIM E, et al. Assessment and Management of Foot Ulcers for People with Diabetes (second edition)[DB/OL]. https: //rnao. ca/bpg/guidelines/assessment-and-management-foot-ulcers-people-diabetes-second-edition.2013-03/2023-12-07. [21] SCHAPER N C, NETTEN J, APELQVIST J, et al.Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update)[J]. Diabetes Metab Res Rev, 2020, 36(S1): e3266. [22] THE AMERICAN DIABETES ASSOCIATION (ADA). Improving care and promoting health in populations: standards of medical care in diabetesd 2019[J]. Diabetes Care, 2019, 42: S46-S60. [23] 米雪梅. 糖尿病教育对糖尿病足护理的影响[J]. 临床老年杂志, 2002, 5(4: ): 297-298. [24] WANG H, LIU T, QIU Q, et al.Development and validation of a simple risk score for prevalent undisagnosed type 2 diabetes in Southern Chinese population[J]. International Journal of Diabetes in Developing Countries, 2015, 35(3): 1-9. [25] 萧茂. 糖尿病足的预防及护理措施[J]. 检验医学与临床, 2016, 09(9): 740-741. [26] MUELLER MJ, SINACORE DR, HASTINGS MK, et al. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial[J]. J Bone Joint Surg Am, 2003, 85-A(8): 1436-1445. [27] WANG W, ZHANG X, CHAO N N, et al.Preparation and characterization of pro-angiogenic gel derived from small intestinal submucosa[J]. Acta Biomater, 2016, 29: 135-148. [28] CAZZELL SM, LANGE DL, DICKRSONJE JR, et al.The Management of Diabetic Foot Ulcers with Porcine Small Intestine Submucosa Tri-Layer Matrix: A Randomized Controlled Trial[J]. Adv Wound Care, 2015, 4(12): 711-718. [29] NIEZGODA J A, VAN GILS C C, FRYKBERG R G, et al. Randomized Clinical Trial Comparing OASIS Wound Matrix to Regranex Gel for Diabetic Ulcers[J]. Adv Skin Wound Care, 2005, 18(5): 258-266. [30] MOSTOW E N, HARAWAY G D, DALSING M, et al.Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: A randomized clinical trial[J]. J Vasc Surg, 2005, 41(5): 837-843. [31] 高炬, 曾庆枝, 何燕玲, 等. 上海市2012年社区在册糖尿病和高血压患者抑郁、焦虑阳性率及其影响因素[J]. 中国公共卫生, 2018, 34(2): 223-229. DOI: 10.11847/zgggws1113306. [32] 谭潇, 于普林. 多学科老年医学团队工作[J]. 中华老年医学杂志, 2015, 34(7): 706-708. [33] 赵风春, 吴润梅.2型糖尿病伴焦虑症社会因素分析[J]. 山西职工医学院学报, 2010, 20(2): 59-60. [34] ANDERSON RJ, FREEDL AND KE, LUSTMAN PJ.The prevalence of co-morbid depression in adults with diabetes: a meta-analysis[J]. Diabetes Care, 2001, 24: 1069-1078. [35] ALI S, STONE MA, PETERS Jl, et al.The prevalence of co-mobid depression in adults with type 2 diabetes: a systematic review and meta-analysis[J]. Diabet Med, 2006, 23: 1165-1173. [36] EGEDE LE, NIETERT PJ, ZHENG D.Depression and all-cause and coronary heart disease mortality among adults with and without diabetes[J]. Diabetes Care, 2005, 28: 1339-1345. [37] MASMOUDI JAWAHER, DAMAK RAHMA, ZOUARI HELA, et al.Prevalence and Impact of Anxiety and Depression on Type 2 Diabetes in Tunisian Patients over Sixty Years Old[J]. Depress Res Treat, 2013, 2013: 341782. [38] EGEDE LEONARD E, ELLIS CHARLES.The effects of depression on metabolic control and quality of life in indigent patients with type 2 diabetes[J]. Diabetes Technol Ther, 2010, 12(4): 257-262.
2023, Vol. 20 
